Key Findings:  This review highlights cannabidiol's (CBD) promising immunomodulatory, anti-inflammatory, and antitumoral effects in chronic inflammatory conditions, viral infections, neurodegenerative diseases, and cancer, emphasizing its therapeutic mechanisms via the immune and endocannabinoid systems, though further clinical studies are needed for translational applications.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  France, Morocco, United States
Year of Pub:  2022
Cannabinoids Studied:  Cannabidiol (CBD)
Phytocannabinoid Source:  Unspecified
Citation:  Aziz AI, et al. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations. Cannabis Cannabinoid Res. 2023; 8:254-269. doi: 10.1089/can.2022.0133
Authors:  Aziz AI, Nguyen LC, Oumeslakht L, Bensussan A, Ben Mkaddem S